This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Fluarix

GlaxoSmithKline plc

Drug Names(s): Alpha-Rix, Influsplit SSW

Description: Fluarix is an unadjuvanted trivalent split virus vaccine manufactured in a GSK facility in Germany from virally infected chicken eggs. Each 0.5 ml dose of Fluarix contains 15 micrograms ofhighly purified sub-units of each of the three influenza virus strains.

Fluarix is used to prevent type A and B influenza. The vaccine works by causing the body to produce its own protection (antibodies) against three different strains of influenza virus. Each year new strains of influenza virus can appear, so every year Fluarix is changed to contain fragments of the new strains of virus.

Fluarix News

Pink Sheet Fluarix BLA filed

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug